On Friday, Gilead Sciences, Inc. (GILD) stock saw a decline, ending the day at $88.4 which represents a decrease of $-3.71 or -4.03% from the prior close of $92.11. The stock opened at $91.71 and ...
On Friday, MannKind Corp (MNKD) stock saw a decline, ending the day at $6.8 which represents a decrease of $-0.22 or -3.13% from the prior close of $7.02. The stock opened at $7.05 and touched a low ...
CVS Health said on Monday it added four new members to its board including hedge fund Glenview Capital's chief executive Larry Robbins as part of a standstill agreement with the activist investor. The ...
CVS Health has added four new board members, including the CEO of a hedge fund that has been critical of the struggling ...
Analyst Mani Foroohar of Leerink Partners maintained a Buy rating on RegenXBio (RGNX – Research Report), boosting the price target to $38.00. Don't Miss our Black Friday Offers: Discover the latest ...
Research analysts at Leerink Partnrs decreased their Q1 2025 earnings estimates for shares of Ardent Health Partners in a ...
Equities researchers at Leerink Partnrs decreased their FY2024 earnings per share (EPS) estimates for Vincerx Pharma in a ...
Leerink Partners analyst Mani Foroohar maintained a Hold rating on CureVac (CVAC – Research Report) on November 12. The company’s ...
Fintel on MSN4d
Leerink Partners Downgrades 908 Devices (MASS)Fintel reports that on November 13, 2024, Leerink Partners downgraded their outlook for 908 Devices (NasdaqGM:MASS) from ...
As a wave of patent expirations encroaches upon many of the world’s top drugmakers, companies will need to be diligent in ...
Fintel reports that on November 12, 2024, Leerink Partners upgraded their outlook for Bristol-Myers Squibb Company - ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback